Simon P.L. Travis
Impact in
- Genetics top 0.02%
- Inflammatory Bowel Disease
- Gastroenterology top 0.05%
- Gastrointestinal Bleeding Diagnosis and Treatment
Papers in
- Genetics 289
- Inflammatory Bowel Disease 278
- Epidemiology 130
- Microscopic Colitis 114
- Autoimmune and Inflammatory Disorders 18
- Co-authors
- Gert Van Assche (17 shared papers)Axel U Dignass (18 shared papers)Markus Friedrich Neurath (1 shared paper)Eduard Friedrich Stange (10 shared papers)Jean Fred Colombel (21 shared papers)Walter Reinisch (20 shared papers)Gerassimos J. Mantzaris (6 shared papers)Bryan F. Warren (16 shared papers)
- Journals
- Journal of Crohn s and Colitis (68 papers)Gastroenterology (51 papers)Gut (46 papers)Alimentary Pharmacology & Therapeutics (25 papers)Inflammatory Bowel Diseases (24 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Simon P.L. Travis
440 papers receiving 33.4k citations
Simon P.L. Travis's Hit Papers
Peers
Comparison fields: 5 of 168
- Genetics 20.5k
- Gastroenterology 3.2k
- Epidemiology 9.3k
- Immunology 4.3k
- Surgery 6.5k
Countries citing papers authored by Simon P.L. Travis
This map shows the geographic impact of Simon P.L. Travis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon P.L. Travis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon P.L. Travis more than expected).
Fields of papers citing papers by Simon P.L. Travis
This network shows the impact of papers produced by Simon P.L. Travis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon P.L. Travis. The network helps show where Simon P.L. Travis may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon P.L. Travis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 462 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Hit paper breakdown → | 2015 | 1517 |
| 2 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management Hit paper breakdown → | 2012 | 1357 |
| 3 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Hit paper breakdown → | 2012 | 1314 |
| 4 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management Hit paper breakdown → | 2010 | 1247 |
| 5 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis Hit paper breakdown → | 2010 | 1137 |
| 6 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis Hit paper breakdown → | 2012 | 726 |
| 7 | Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial Hit paper breakdown → | 2017 | 725 |
| 8 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Hit paper breakdown → | 2009 | 719 |
| 9 | Mucosal healing in inflammatory bowel diseases: a systematic review Hit paper breakdown → | 2012 | 701 |
| 10 | Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease Hit paper breakdown → | 2017 | 633 |
| 11 | 1996 | 604 | |
| 12 | IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease Hit paper breakdown → | 2011 | 556 |
| 13 | The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease Hit paper breakdown → | 2014 | 553 |
| 14 | A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21 Hit paper breakdown → | 2007 | 543 |
| 15 | Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Hit paper breakdown → | 2011 | 512 |
| 16 | Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit Hit paper breakdown → | 2011 | 508 |
| 17 | Development of the Crohnʼs disease digestive damage score, the Lémann score Hit paper breakdown → | 2010 | 487 |
| 18 | 2006 | 478 | |
| 19 | 2008 | 443 | |
| 20 | 2008 | 432 |
About Simon P.L. Travis
Simon P.L. Travis is a scholar working on Genetics, Epidemiology, Gastroenterology, Surgery and Immunology, having authored 462 papers that have together received 34.3k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (278 papers), Microscopic Colitis (114 papers), Helicobacter pylori-related gastroenterology studies (27 papers), Eosinophilic Esophagitis (21 papers), Gastrointestinal Bleeding Diagnosis and Treatment (19 papers), Autoimmune and Inflammatory Disorders (18 papers), Immunodeficiency and Autoimmune Disorders (17 papers) and Celiac Disease Research and Management (14 papers). The work is most often cited by research in Genetics (20.5k citations), Gastroenterology (3.2k citations), Epidemiology (9.3k citations), Immunology (4.3k citations) and Surgery (6.5k citations). Simon P.L. Travis has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Gert Van Assche, Axel U Dignass, Markus Friedrich Neurath, Eduard Friedrich Stange, Jean Fred Colombel, Walter Reinisch, Gerassimos J. Mantzaris, Bryan F. Warren, James Oliver Lindsay and Alissa J. Walsh. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Gut, Alimentary Pharmacology & Therapeutics and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.